Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Urinary Incontinence-Targeting Compound 1, used in the research of urinary incontinence, is a sulfonanilide derivative.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 1,520.00 | |
50 mg | 6-8 weeks | $ 1,980.00 | |
100 mg | 6-8 weeks | $ 2,500.00 |
Description | Urinary Incontinence-Targeting Compound 1, used in the research of urinary incontinence, is a sulfonanilide derivative. |
In vitro | Urinary Incontinence-Targeting Compound 1,used in the research of urinary incontinence. |
Molecular Weight | 248.27 |
Formula | C9H13FN2O3S |
CAS No. | 137315-05-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Urinary Incontinence-Targeting Compound 1 137315-05-0 Others Urinary Incontinence Targeting Compound 1 Urinary IncontinenceTargeting Compound 1 inhibitor inhibit